News Blog

New Lung cancer drug cuts death risk by half, study finds A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily.
Group urges Tinubu to strengthen, implement tobacco control laws A non-governmental organisation, Nigeria Tobacco Control Alliance has urged President Bola Tinubu to champion the strengthening and implementation of tobacco control laws to protect the health…
Prioritise local drug manufacturing, health insurance, stakeholders task Tinubu Stakeholders in the health sector have urged President Bola Tinubu to address the lingering health issues in the country.
NDLEA Busts Lethal Drug Syndicate, Arrests Members In Anambra Operatives of the National Drug Law Enforcement Agency have arrested members of a syndicate involved in the illicit importation and trafficking of the lethal synthetic…
Nigerian pharmacists lament scarcity of ‘widely used’ GSK drugs Pharmacists have lamented the scarcity of drugs produced by GlaxoSmithKline in Nigeria.
Healthy, moderate eating curbs contraceptive-induce weight gain – Expert Maternal health experts say some family planning methods like the implant, injectable and oral tablets are hormonal-based and therefore, can cause weight gain in women using…
Packaging drinks in used plastic bottles unsafe- Experts Medical and food safety professionals have kicked against the practice of bottling locally made drinks in plastic bottles, noting that it is unsafe for consumption and dangerous…
Packaging drinks in used plastic bottles unsafe- Experts Medical and food safety professionals have kicked against the practice of bottling locally made drinks in plastic bottles, noting that it is unsafe for consumption and dangerous…
WMA president urges humane, patient-centred medical practice
Little evidence antidepressants help chronic pain, study says There is little evidence that most antidepressants are effective against chronic pain, the largest study conducted on the subject
Page 1 of 72

Information

NIROPHARM is dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. 

Some of the challenges that NIROPHRM is set  to tackle with all the resources it has at its disposal include: High cost of funds, Poor infrastructure, Poor IPR protection, Chaotic drug distribution, Lack of data for planning, High level of Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance particularly at the land borders